Avanos Medical Inc (FRA:8HH)
€ 21.6 +0.20 (+0.93%) Market Cap: 1.03 Bil Enterprise Value: 1.09 Bil PE Ratio: 0 PB Ratio: 1.49 GF Score: 62/100

Avanos Medical Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 11:45PM GMT
Release Date Price: €16.2
Unidentified Participant

Welcome. My name is [Charles Walsh], administers the JPMorgan. It's my pleasure to introduce Joe Woody, CEO of Arvinas.

Joe Woody Avanos Medical
Inc. - CEO

Thank you, Charles, and thank you, everyone, here in the room and those of you that are listening on the webcast. I'm very excited to update on a three year transformation that we talked about here in this very room actually last year. So I want to give an indication of how we did in our first year, give you a report card and then talk about what's next.

And one thing I would say is that the organization really accomplished a lot. In year one, we divested a portion of our business that we executed on M&A, and we did a lot of restructuring and cost-out in the total company. So we'll come onto that in a bit and highlight that as we go forward.

I would say that for us as a management team, the one thing we have left in the transformation to execute on is consistent and sustainable organic growth. I'm going to spend just a little bit of time covering our pain management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot